On October 7, ASYMCHEM fell 3.87% in regular trading, trading at HK$163.2, with a turnover of HK$608,800. The decline follows a series of institutional stake reductions in the company's H-shares, which have pressured market sentiment amid pre-holiday risk aversion.

According to exchange disclosures, JPMorgan sold 83,200 H-shares off-market on September 23 at an average price of HK$159.1287, reducing its long position to 8.8%. Schroders PLC also reduced its holding on September 24, selling 175,800 shares at approximately HK$150.23 each. These consecutive institutional sell-downs have compounded negative sentiment, despite the company's fundamentally solid backdrop.

The company's fundamentals remain strong, with an order backlog of US$1.673 billion, up 53.77% year-over-year, and its chemical macromolecule manufacturing base recently passed a U.S. FDA pre-approval inspection. However, pre-holiday risk aversion and foreign capital repositioning have overshadowed these positive developments, leaving the share price under pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)